Cargando…
Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax
Introduction: Pneumothorax is a condition that usually occurs in thin, young people, especially in smokers. It is an unusual complication of COVID-19 disease that can be associated with worse results. This disease can occur without pre-existing lung disease or without mechanical ventilation. Materia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504188/ https://www.ncbi.nlm.nih.gov/pubmed/36143919 http://dx.doi.org/10.3390/medicina58091242 |
_version_ | 1784796152986599424 |
---|---|
author | Nistor, Claudiu-Eduard Pantile, Daniel Stanciu-Gavan, Camelia Ciuche, Adrian Moldovan, Horatiu |
author_facet | Nistor, Claudiu-Eduard Pantile, Daniel Stanciu-Gavan, Camelia Ciuche, Adrian Moldovan, Horatiu |
author_sort | Nistor, Claudiu-Eduard |
collection | PubMed |
description | Introduction: Pneumothorax is a condition that usually occurs in thin, young people, especially in smokers. It is an unusual complication of COVID-19 disease that can be associated with worse results. This disease can occur without pre-existing lung disease or without mechanical ventilation. Materials and Methods: We present a monocentric comparative retrospective study of diagnostic and treatment analysis of two groups of patients diagnosed with COVID-19 and non-COVID-19 pneumothorax. All patients included in this study underwent surgery in a thoracic surgery department. The study was conducted over a period of 18 months. It included 34 patients with COVID-19 pneumothorax and 42 patients with non-COVID-19 pneumothorax. Results: The clinical symptoms were more intense in patients with COVID-19 pneumothorax. We found that the patients with COVID-19 had significantly more respiratory comorbidities. Diagnostic procedures include chest CT exam for both groups. Laboratory findings showed that increasing values for the analyzed data were consistent with the deterioration of the general condition and the appearance of pneumothorax in the COVID-19 group. The therapeutic attitude regarding the non-COVID-19 group was to eliminate the air from the pleural cavity and surgical approach to the lesion that determined the occurrence of pneumothorax. The group of patients with COVID-19 pneumothorax received systemic treatment, and only minimal pleurotomy was performed. The surgical approach did not alter patients’ survival. Conclusions: Careful monitoring of the patient’s clinic and laboratory tests evaluating the degradation of the lung parenchyma, correlated with the imaging examination (chest CT) is mandatory and reduces COVID-19 complications. Early imaging examination starts an effective diagnosis and treatment management. In severe COVID-19 pneumothorax cases, the pneumothorax did not influence the evolution of COVID-19 disease. When we found that the general condition worsened with the rapid progression of dyspnea and the deterioration of the general condition, and we found that it represented the progression or recurrence of pneumothorax. |
format | Online Article Text |
id | pubmed-9504188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95041882022-09-24 Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax Nistor, Claudiu-Eduard Pantile, Daniel Stanciu-Gavan, Camelia Ciuche, Adrian Moldovan, Horatiu Medicina (Kaunas) Article Introduction: Pneumothorax is a condition that usually occurs in thin, young people, especially in smokers. It is an unusual complication of COVID-19 disease that can be associated with worse results. This disease can occur without pre-existing lung disease or without mechanical ventilation. Materials and Methods: We present a monocentric comparative retrospective study of diagnostic and treatment analysis of two groups of patients diagnosed with COVID-19 and non-COVID-19 pneumothorax. All patients included in this study underwent surgery in a thoracic surgery department. The study was conducted over a period of 18 months. It included 34 patients with COVID-19 pneumothorax and 42 patients with non-COVID-19 pneumothorax. Results: The clinical symptoms were more intense in patients with COVID-19 pneumothorax. We found that the patients with COVID-19 had significantly more respiratory comorbidities. Diagnostic procedures include chest CT exam for both groups. Laboratory findings showed that increasing values for the analyzed data were consistent with the deterioration of the general condition and the appearance of pneumothorax in the COVID-19 group. The therapeutic attitude regarding the non-COVID-19 group was to eliminate the air from the pleural cavity and surgical approach to the lesion that determined the occurrence of pneumothorax. The group of patients with COVID-19 pneumothorax received systemic treatment, and only minimal pleurotomy was performed. The surgical approach did not alter patients’ survival. Conclusions: Careful monitoring of the patient’s clinic and laboratory tests evaluating the degradation of the lung parenchyma, correlated with the imaging examination (chest CT) is mandatory and reduces COVID-19 complications. Early imaging examination starts an effective diagnosis and treatment management. In severe COVID-19 pneumothorax cases, the pneumothorax did not influence the evolution of COVID-19 disease. When we found that the general condition worsened with the rapid progression of dyspnea and the deterioration of the general condition, and we found that it represented the progression or recurrence of pneumothorax. MDPI 2022-09-08 /pmc/articles/PMC9504188/ /pubmed/36143919 http://dx.doi.org/10.3390/medicina58091242 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nistor, Claudiu-Eduard Pantile, Daniel Stanciu-Gavan, Camelia Ciuche, Adrian Moldovan, Horatiu Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title | Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title_full | Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title_fullStr | Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title_full_unstemmed | Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title_short | Diagnostic and Therapeutic Characteristics in Patients with Pneumotorax Associated with COVID-19 versus Non-COVID-19 Pneumotorax |
title_sort | diagnostic and therapeutic characteristics in patients with pneumotorax associated with covid-19 versus non-covid-19 pneumotorax |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504188/ https://www.ncbi.nlm.nih.gov/pubmed/36143919 http://dx.doi.org/10.3390/medicina58091242 |
work_keys_str_mv | AT nistorclaudiueduard diagnosticandtherapeuticcharacteristicsinpatientswithpneumotoraxassociatedwithcovid19versusnoncovid19pneumotorax AT pantiledaniel diagnosticandtherapeuticcharacteristicsinpatientswithpneumotoraxassociatedwithcovid19versusnoncovid19pneumotorax AT stanciugavancamelia diagnosticandtherapeuticcharacteristicsinpatientswithpneumotoraxassociatedwithcovid19versusnoncovid19pneumotorax AT ciucheadrian diagnosticandtherapeuticcharacteristicsinpatientswithpneumotoraxassociatedwithcovid19versusnoncovid19pneumotorax AT moldovanhoratiu diagnosticandtherapeuticcharacteristicsinpatientswithpneumotoraxassociatedwithcovid19versusnoncovid19pneumotorax |